Company / AR per Share
Amphstar Pharmaceuticals, Inc. AR per Share History
FY2016-FY2025 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest AR per Share
$3.01
FY2025
5-year range
$1.66 / $3.01
FY2021-FY2025
Trend
+6.3%
vs FY2024
Sector context
#34 of 113
Health Care
What the data says
At $3.01, Amphstar Pharmaceuticals, Inc.'s ar per share ranks #34 of 113 in the Health Care sector. AR per Share has increased for 6 consecutive years, from $0.97 in FY2019 to $3.01 in FY2025.
Based on SEC 10-K filings.
3.01 in FY2025 with a 5-year CAGR of +16.3%.
Improved from $2.39 to $3.01 over the past 2 years.
Health Care sector context is included.
AR per Share over time
Growth rates
- 3-Year CAGR
- +17.4%
- 5-Year CAGR
- +16.3%
- 10-Year CAGR
- -
Sector benchmark
#34 of 113 in Health CareTop 30% of 113This company $3.01 Sector average $28.83
▼
-89.5% below sector average
Key checks
Key Insights
- Amphstar Pharmaceuticals, Inc.'s ar per share has grown for 6 consecutive years.
- In FY2025, ar per share increased 6.3% year-over-year.
- Ranks #34 out of 113 companies in the Health Care sector.
- Lowest ar per share in the period was in FY2016.
Company context
Key Data Points
- Strong profit margin: 21.8%
- High earnings quality (cash-backed earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | AR per ShareValue | YoY GrowthYoY |
|---|---|---|
| FY2025 | $3.01 | +6.3% |
| FY2024 | $2.84 | +18.7% |
| FY2023 | $2.39 | +28.4% |
| FY2022 | $1.86 | +12.2% |
| FY2021 | $1.66 | +17.1% |
| FY2020 | $1.42 | +45.6% |
| FY2019 | $0.97 | -13.0% |
| FY2018 | $1.12 | +43.7% |
| FY2017 | $0.78 | +31.4% |
| FY2016 | $0.59 | -20.4% |
As of FY2025 · SEC 10-K · Updated Feb 28, 2026